Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Evaluation for NCI Surgery Branch Clinical Research Protocols
NCI's Surgery Branch Clinical Research Protocols are currently recruiting for multiple cancer studies, including synovial sarcoma, melanoma,…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Immediate Lymphatic Reconstruction After Lymphadenectomy in Melanoma Patients: a Parallel Cohort Pilot Study [NA]
A pilot parallel-cohort clinical trial evaluating immediate lymphatic reconstruction after lymphadenectomy in melanoma patients; the study i…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Natural History Study of Early Life Exposures in Agriculture (ELEA)
An update on the ELEA natural history study sponsored by the National Cancer Institute investigating how early life exposures in agriculture…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies [Phase 2]
Phase 2 clinical trial evaluating a PD-1–blocking monoclonal antibody in combination with a metabolic modulator for several solid tumors is …
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Study of DXC014 in Patients With Advanced Solid Tumors. [Phase 1]
Phase 1 study of the investigational drug DXC014 in advanced solid tumors is currently recruiting. It includes patients with small cell lung…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Intratumoral Targeted Hyperthermia Therapy (THT) for Cutaneous Metastatic Melanoma [NA]
A clinical trial update for Intratumoral Targeted Hyperthermia Therapy (THT) in cutaneous metastatic melanoma, currently not yet recruiting …
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Clinical Genetics Branch Eligibility Screening Survey
National Cancer Institute conducts an eligibility screening survey for a clinical trial spanning multiple cancer predisposition conditions, …
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Trial of Pembrolizumab and Radiotherapy in Melanoma [Phase 2]
A Phase 2 trial evaluating pembrolizumab in combination with radiotherapy for melanoma has been terminated, with results posted on 2026-04-2…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A PK Study to Compare GME751 (Proposed Pembrolizumab Biosimilar) and US-licensed and EU-authorized Keytruda® in Participants With Stage II and III Melanoma [Phase 1]
A phase 1 PK study comparing GME751, a proposed pembrolizumab biosimilar by Sandoz, to Keytruda in participants with stage II-III melanoma; …
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Phase II Study of Neoadjuvant Pembrolizumab & Lenvatinib for Resectable Stage III Melanoma [Phase 2]
A Phase II trial evaluating neoadjuvant pembrolizumab plus lenvatinib in patients with resectable stage III melanoma; the study is currently…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
AstraZeneca is conducting a Phase 1/2 trial to evaluate the safety of AZD6750 in adults with select advanced or metastatic solid tumors; the…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations. [Phase 1]
Pfizer's PF-07799933 is being studied in a Phase 1 trial for advanced solid tumors with BRAF alterations. The study includes melanoma, non-s…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma [Phase 2]
This entry notes a phase 2 clinical trial evaluating fianlimab, cemiplimab, and ipilimumab in advanced melanoma and indicates the trial is c…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors [Phase 1]
Pfizer is conducting a Phase 1 study of PF-07799544 as a monotherapy or in combination for advanced solid tumors, including melanoma and gli…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: MElanoma Research Lymph Node Prediction Implementation National_001
This document updates an ongoing nationwide melanoma study focused on implementing lymph node prediction, with the trial currently active bu…
-
EMA approval · 2026-04-22EMA Authorised: Keytruda (pembrolizumab) — Merck Sharp & Dohme B.V.
The European Medicines Agency authorised Keytruda (pembrolizumab) for multiple cancer indications, including melanoma, Hodgkin lymphoma, ren…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma [Phase 2, Phase 3]
A clinical trial update announces a Phase 2/Phase 3 study of LNS8801 with or without pembrolizumab in patients with refractory melanoma, and…
-
CLINICAL_TRIALS other · 2026-04-22Clinical Trial Update: Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma [Phase 3]
Phase 3 trial update for Fianlimab in combination with Cemiplimab versus Pembrolizumab in adolescent and adult patients with previously untr…
-
CLINICAL_TRIALS other · 2026-04-22Clinical Trial Update: Fianlimab&Cemiplimab as TotalNeoadj The (TNT) ForMelanoma [Phase 2]
Phase 2 clinical trial update evaluating total neoadjuvant therapy with Fianlimab and Cemiplimab for melanoma; currently not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Aerosolized Aldesleukin in Treating Patients With Lung Metastases [Phase 1]
Phase 1 study evaluating aerosolized aldesleukin (interleukin-2) in patients with cancers that have metastasized to the lung, including mela…
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: A Phase 1/2 Randomized, Blinded, Placebo Controlled Study of Ipilimumab in Combination With Epacadostat or Placebo in Subjects With Unresectable or Metastatic Melanoma [Phase 1, Phase 2]
A phase 1/2 randomized trial evaluated ipilimumab plus epacadostat vs ipilimumab plus placebo in unresectable or metastatic melanoma; the st…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab [Phase 4]
Phase 4 study evaluating ctDNA-guided addition of ipilimumab to patients receiving nivolumab and relatlimab for metastatic or advanced melan…
-
CLINICAL_TRIALS withdrawal · 2026-04-21Clinical Trial Update: Surgical or Radiotherapeutic Intervention Concerning Large Singular Stable to Progressive Metastases in Patients With BRAFV600-mutated Melanoma Receiving Treatment With Encorafenib + Binimetinib [Phase 4]
A Phase 4 clinical trial evaluating surgical or radiotherapeutic intervention for large singular metastases in BRAFV600-mutated melanoma pat…
-
CLINICAL_TRIALS safety_alert · 2026-04-20Clinical Trial Update: Expanded Access Program of AMTAGVI That is Out of Specification for Commercial Release
Expanded Access program for AMTAGVI is out of specification for commercial release, triggering quality controls and potential safety concern…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study to Test How BI 765063 and BI 770371 Are Taken up in Tumours of People With Different Types of Advanced Cancer Who Are Also Taking Ezabenlimab [Phase 1]
A Phase 1 clinical trial evaluating how BI 765063 and BI 770371 are taken up in tumors of patients with advanced cancers who are receiving e…